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Abstract
Background/Objectives: Physiological evidence indicates that high-protein diets reduce caloric intake and increase
thermogenic response, which may prevent weight gain and regain after weight loss. Clinical trials have shown such effects,
whereas observational cohort studies suggest an association between greater protein intake and weight gain. In both types
of studies the results are based on average weight changes, and show considerable diversity in both directions. This study
investigates whether the discrepancy in the evidence could be due to recruitment of overweight and obese individuals into
clinical trials.
Subjects/Methods: Data were available from the European Diet, Obesity and Genes (DiOGenes) post-weight-loss weight-
maintenance trial and the Danish Diet, Cancer and Health (DCH) cohort. Participants of the DCH cohort were matched with
participants from the DiOGenes trial on gender, diet, and body characteristics. Different subsets of the DCH-participants,
comparable with the trial participants, were analyzed for weight maintenance according to the randomization status (high
or low protein) of the matched trial participants.
Results: Trial participants were generally heavier, had larger waist circumference and larger fat mass than the participants in
the entire DCH cohort. A better weight maintenance in the high-protein group compared to the low protein group was
observed in the subgroups of the DCH cohort matching body characteristics of the trial participants.
Conclusion: This modified observational study, minimized the differences between the RCT and observational data with
regard to dietary intake, participant characteristics and statistical analysis. Compared with low protein diet the high protein
diet was associated with better weight maintenance when individuals with greater body mass index and waist
circumference were analyzed. Selecting subsets of large-scale observational cohort studies with similar characteristics as
participants in clinical trials may reconcile the otherwise conflicting results.
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Introduction
Physiological evidence indicates that a high intake of protein
may increase thermogenic response and reduce caloric intake by
increased satiety [1–3]. Randomized, controlled trials (RCTs) have
suggested an overall beneficial effect of high-protein diets on
weight loss and weight maintenance after weight loss [4,5]. In
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contrast, large-scale, long-term observational cohort studies have
shown that greater protein intake is associated with weight gain
[6,7]. Although results from RCTs and observational studies often
reach similar results [8–12], the sometimes conflicting findings
make the formation of health recommendations difficult. Herna´n
et al. [13] addressed the conflicting results for the association
between hormone replacement therapy in postmenopausal women
and risk of coronary heart disease. In an analysis where
characteristics of the RCT was mimicked in the observational
data, the association in the modified observational study approx-
imated the result of the RCT. Potentially, other areas in medicine
showing diverse results in observational studies versus RCTs may
also be due to different participant and study characteristics rather
than by diverse exposure-disease associations per se.
In the study of dietary protein and weight regulation, the results
from RCTs and observational studies are based on average weight
changes, and show considerable diversity in both directions. RCTs
have commonly investigated overweight and obese individuals
only, while observational studies have also included normal and
underweight individuals. Moreover, the dietary protein intake in
the high-protein arm of RCTs has been much higher than the
average habitual protein intake in observational studies. We
speculate if these differences are important to find an, on average,
beneficial effect of protein.
This would correspond to effect-modification by the selection
criteria. Individuals recruited for the trial could be represented by
a subset of the broader population included in the observational
study. Identifying such subset of individuals in observational data,
and making the statistical analysis similar to the trial counterpart,
may resolve what seemed to be conflicting results.
The aim of the present study was to investigate whether
subgroups of participants from a cohort study comparable to
participants from a trial experiencing a beneficial effect of dietary
protein on weight maintenance could be identified.
Subjects and Methods
The participants in the DiOGenes trial [5], showing better
weight loss maintenance with a high protein intake, were matched
on gender, diet and body characteristics in the observational
Danish Diet, Cancer and Health (DCH) cohort study, showing a
tendency to weight gain with greater protein intake [6].
The DiOGenes trial [5] had an initial eight weeks low-calorie
diet (LCD) weight loss phase, and investigated how the ratio of
protein-carbohydrate intake and glycemic index (GI) influenced
weight maintenance during six months (mean durations). The
participants were overweight or obese adults from eight European
countries. Out of 773 participants completing the weight loss
phase, 548 completed the weight-maintenance intervention of one
of five randomly allocated, ad libitum diets, all low in fat (25–30
energy percent [E%] fat). The five intervention diets were: 1) low
protein (13 E%) and low GI, 2) low protein and high GI, 3) high
protein (25 E%) and low GI, 4) high protein and high GI, or 5) a
control diet based on local recommendations of a healthy diet.
Weight was measured at randomization and during the interven-
tion period by trained personnel. Three-day food diaries were
obtained approximately four weeks after randomization. The trial
has been described in detail elsewhere [5] and is registered with
ClinicalTrials.gov, number NCT00390637.
In the DCH cohort study, individuals living in the area of
Copenhagen or Aarhus, Denmark, aged 50–64 without a
diagnosis of cancer registered in the Danish Cancer Registry were
invited. Baseline diet was obtained by a validated food frequency
questionnaire. Weight was measured by trained personnel at
baseline and obtained by self-measurements at follow-up five years
later (mean duration). The DCH cohort study has been described
in detail elsewhere [14]. Out of 160 725 invited, 57 053 individuals
were examined. In accordance with the observational DiOGenes
study [15], a generally healthy sub-cohort with available
information was selected for further analyses. The following
inclusion criteria were employed: available measures on weight at
baseline and at follow-up, available measure of baseline height,
available measures of dietary intake, stable smoking habits,
available blood sample, age at baseline ,60 years and age at
follow-up,65 years, average weight gain #5 kg/year, absence of
known diabetes, cancer or cardiovascular disease diagnosed before
or during the follow-up period. As an indicator of health status,
individuals with a weight loss .5 kg/year were also excluded. In
total, 22 835 individuals, ranging from underweight to obese, met
these criteria, and thus constituted the final study population for
the present study (Figure 1). When investigated as a part of the
DiOGenes observational study [6], the DCH cohort showed a
tendency towards an association between greater protein and
Figure 1. Flow chart of the Danish Diet, Cancer and Health
cohort.
doi:10.1371/journal.pone.0101134.g001
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weight gain when analyzed with an energy partition model in a
multiple linear regression, but without statistical significance.
Access to the data from both studies; the DiOGenes trial data
and the DCH cohort data have been generated for many other
purposes than the present study. Access to the data requires an
application submitted to and subsequently approved by the
respective Steering Boards of the studies. Contact professor Wim
HM Saris (W.Saris@maastrichtuniversity.nl) and head of research
Anne Tjønneland (annet@cancer.dk) for request to acces to the
DiOGenes trial data and to the Danish Diet, Cancer and Health
cohort data, respectively. Participants in both the DiOGenes trial
and the DCH cohort provided written informed consent, and the
studies were approved by the relevant scientific committees
[14,16].
Matching
Matching was implemented in a sex-specific manner (i.e.
women were matched with women, and men with men). The
main matching variables were the dietary exposure variables used
in the trial [5] (intake of protein E%, carbohydrate E% and GI) to
aim for a similar distribution of the diet in the selected DCH
participants as in the trial. As mentioned, only overweight or obese
individuals were included in the DiOGenes trial, while body size
was not an inclusion criterion in the DCH cohort study. Hence,
body characteristic may potentially be effect-modifiers. The
following variables describing body characteristics were identified
for matching: body mass index (BMI, kg/m2), waist circumference
(WC) and fat mass index (FMI; calculated by dividing kg of fat
mass with height-squared in meters, kg/m2). In total, five
combinations were matched: 1) only on dietary variables (protein
E%, carbohydrate E% and GI), 2) dietary variables and BMI, 3)
dietary variables and WC, 4) dietary variables and FMI or 5)
dietary variables, BMI and WC.
The matching was based on similarities calculated by the
normalized Euclidean distance metric [17] on the defined sets of
variables. Trial participants were sequentially considered and the
available DCH participant that, in each case, showed the closest
match (the smallest distance) was selected without replacement.
The normalization was made such that each contributing distance
term was weighted by the inverse of the variance of the
corresponding variable within the DCH cohort; thus, all variables
were effectively treated as standardized to a unit standard
deviation within the cohort.
Since matching was done without replacement and by
sequentially scanning through the trial data, the matching could
depend on the initial order of the individuals in the trial dataset.
To take this into account, matching was done based on ten distinct
random orders of the trial dataset.
To increase the sample size and hence statistical power, multiple
DCH participants were matched to each trial participant. After
the first full scan of the trial data, a second iteration was started,
etc. However, with an increasing number of iterations, the
distances of the matches increase; hence there is a trade-off
between sample size and matching quality. To decide how many
DCH participants to match each trial participant, scree plots
(mean matching distance scores plotted against matching iteration
numbers) [18] were inspected. Figure 2 shows, as an example, a
scree plot, based on one of the random orders of the trial
participants, when matching on protein E%, carbohydrate E%,
GI, BMI and WC. Corresponding graphs based on other
matching-combinations looked similar (not shown). After the third
iteration, the distance-increase began to level off in all scree plots,
so four iterations were used, i.e. four DCH participants were
matched to each trial participant.
The group of individuals selected from the initial observational
cohort data chosen by matching is referred to as the modified
observational data below.
Figure 3 shows the matching-performance when matching on
protein E%, carbohydrate E%, GI, BMI and WC, based on mean
values across matches of the ten random orders of the trial dataset.
For each match-variable, the values of the four DCH participants
are plotted against the value of the matched trial participant.
Corresponding plots based on other match-combinations looked
similar; see Figures S1–S4 in file S1. A hypothetical, perfect match
would have followed the straight line of equality (y = x). As seen, it
was not possible to get a very close match in the observational data
of the greatest protein E% intakes of the trial participants. A
similar, although much less prominent, pattern was observed
regarding match on carbohydrate E% and GI. The match on BMI
and WC was fair, even though deviations tended to increase with
higher values.
Figure 3 also distinguishes between the high and low protein
group (using red square markers and blue triangle markers,
respectively). Considerable variation in protein- and carbohydrate
intake was present within the groups of trial participants
randomized to high or low protein, and hence also among the
participants of the modified observational data.
Statistical analyses
Multiple linear regressions were used in the analyses of the
modified observational data. In the trial [5] participants were
analyzed according to randomization status in an intention-to-
treat manner. To analyze the modified observational data in a
similar manner, the selected DCH participants were analyzed
according to the randomization status of the trial participant they
matched. Similar to the analyses in the trial [5], the five groups
(low protein, low GI; low protein, high GI; high protein, low GI;
high protein, high GI; control) were recoded into three indicator
variables: High protein (yes/no), high GI (yes/no) and control
group (yes/no). This was the exposure in the modified observa-
tional data. Since dietary adherence was not taken into account in
the analyses of the DiOGenes trial [5], it was not done in the
analyses of the modified observational data.
Figure 2. Scree plot. Mean matching distance across match-variables
plotted against matching iteration number (number of observational
participants matched with every trial participant). Matching was based
on protein E%, carbohydrate E%, glycemic index, body mass index and
waist circumference. Example of one of the ten random orders of the
trial dataset is shown. E%: percent of energy intake.
doi:10.1371/journal.pone.0101134.g002
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The outcome in the DiOGenes trial [5] was weight change
during the intervention. In the analyses of the modified
observational data, the weight change from baseline to follow-up
was used as the outcome. Since follow-up time varied within the
DCH cohort, average annual weight change was calculated (kg/
year).
Adjustment for potential confounding was implemented at two
levels: 1) a model with adjustment for baseline BMI and gender
similar to the analysis of the trial [5], and 2) a fully adjusted model
with adjustment for gender (three groups: men, women without
hormone use, women with hormone use), baseline BMI, age,
physical activity (four groups: inactive, moderately inactive,
moderately active, active), education (four groups: primary school,
technical/professional school, secondary school, university degree)
and baseline intake of fibers (grams/day) and alcohol E%. No
adjustment was done for other macronutrients, since exposure
status reflects dietary intake. Total energy intake was not adjusted
for in the main analyses, in order not to adjust for a potential
satiating effect of protein.
Regression analyses were performed for each match-combina-
tion and for each of the ten random orders of the trial dataset.
Mean values of the ten estimated individual regression coefficients
and standard errors of weight change were calculated and
summary p-values derived and presented as the core results.
Statistical analyses were performed in Stata 12.1 (StataCorp LP,
College Station, Texas).
Supplementary analyses
First, analyses of the modified observational data were
performed with additional adjustment for energy intake.
Second, since information on dietary intake was missing for
some trial participants and therefore not matched to the DCH
participants, the trial data were re-analyzed on the subset with
dietary data available. This was performed as a linear regression
based on weight change between randomization and post-
Figure 3. Matching performance. Scatter plot of the selected cohort participants vs. the corresponding, matched trial participant. Matching was
based on protein E%, carbohydrate E%, glycemic index, BMI and WC. Four participants from the cohort data where matched with every trial
participant. Mean values across matches of the ten random orders of the trial dataset are shown. The line of equality, y = x, indicates a perfect match.
Red square marker: low protein group. Blue triangle marker: high protein group. Control group is not shown. Trial participants N = 428, defined by
having available measurements of diet, BMI and WC; matched modified cohort participants N = 1 712. BMI: body mass index. E%: percent of energy
intake. WC: waist circumference.
doi:10.1371/journal.pone.0101134.g003
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intervention and included variables of assigned intervention diet,
coded as indicator variables, gender and baseline BMI.
Third, because of the difficulties in matching on the highest
protein intake reported by trial participants (Figure 3), the trial
data were also re-analyzed similar to above, but with participants
with a protein intake ,30 E%.
Results
Table 1 shows characteristics of trial participants, individuals in
the initial DCH cohort and the modified observational cohort data
when matching on protein E% and carbohydrate E%, GI, BMI
and WC. Characteristics of the modified observational cohort data
is shown as mean values across matches of the ten random orders
of the trial dataset. Corresponding tables based on other match-
combinations looked similar; see Table S1 in file S1. The initial
cohort data showed a median protein intake comparable to the
low protein group of the trial and a median intake of carbohydrate
similar to the high protein group of the trial. Median intake of
protein, carbohydrate and GI were similar in the high and low
protein groups in the trial data and in the modified observational
data. The ranges between the 5th and 95th percentiles of protein,
carbohydrate and GI in the trial data and the modified
observational data were all broad; however, the greatest variation
was seen among the trial participants. The mean, 5th and 95th
percentiles of body measures (BMI, WC and FMI) were slightly
greater in the trial data than in the modified observational data.
However, the mean, 5th and 95th percentiles of the body measures
in the initial cohort was lower than the modified observational
data, indicating that individuals in the modified observational data
were more similar to the trial participants according to these
variables.
Analyzing the modified observational data
Table 2 shows the results of the analyses of the modified
observational dataset from the five distinct match-combinations.
When matched on the dietary variables only, no difference on
average annual weight change was seen between the high and low
protein groups.
When matched on dietary variables in combination with BMI
and WC, simultaneously, the high protein group had significantly
lower weight gain, hence better weight maintenance, than the low
protein group. The other three match-combinations with dietary
variables and BMI, WC and FMI, respectively, showed the same
tendency, although weaker and not reaching significant p-values.
Results from the two adjustment schemes were overall similar.
Supplementary analyses
Comparing results based on fully-adjusted models with/without
additional adjustments for total energy intake showed similar
results (see Table S2 in file S1).
When analyzing trial participants with available information on
diet and weight at randomization and post-intervention (N = 441),
the high protein group had a better weight loss maintenance than
the low protein group (adjusted mean difference: 21.20 kg, 95%
CI: 22.35; 20.05, p = 0.041). When restricting trial participants
further to those with a protein intake,30 E%, (N = 420), a similar
result was obtained (21.31 kg, 95% CI: 22.49; 20.13,
p = 0.0301). These results are similar to the results reported in
the initial trial [5], see Table S3 in file S1.
Discussion
The physiological mechanism supposed to provide a beneficial
effect on weight control of a high protein diet is believed to be
universally valid. A beneficial effect is seen in RCTs among
overweight or obese individuals [4,5]. However the opposite is
seen in observational studies investigating populations including
also under- and normal-weight individuals [6,7]. This study
explored the possibilities of reconcile the conflicting evidence.
Subgroups from the DCH cohort comparable to participants in
the DiOGenes trial [5] were selected. Matching was based on to
gender, macronutrient composition of the diet and body
characteristics (BMI, WC or FMI, respectively, or BMI and
WC). Weight change of the individuals matching the trial
participants randomized to a high protein diet was compared to
weight change of the individuals matching the trial participants
randomized to a low protein diet. In these modified observational
data, a lower weight gain, hence a better weight maintenance, was
seen in the high-protein group than in the low-protein group.
When matched only on diet there was no difference.
These findings suggest that the physiological mechanism behind
a better weight control with a high protein intake should be
reconsidered. A high intake of protein increases of satiety and
thermogenesis [1–3]. Most of these studies were executed in
overweight or obese subjects. From the results of the present study,
it may be speculated that these beneficial effects are only present
given a certain level of adiposity. If this is the case the effects on
satiation and thermogenesis may be more pronounced with for
example increasing BMI. If so, other mechanisms may overrule
these effects among normal weight and underweight individuals.
This is supported by a physiological study where high and low
protein diets were fed to young, healthy, lean subjects; no
differences were seen in insulin levels, appetite or total energy
expenditure [19]. The potential negative energy balance with a
high protein intake may be counteracted by a functional energy
balance regulation. Other mechanisms of a high protein diet may
lead to weight gain. A recent study [20] suggests that the weight
gain associated with high protein intake in a broad population-
based study cannot solely be ascribed to an anabolic effect on fat-
free mass; greater protein intake was associated with gain in both
fat-free mass and fat mass. Hence, high intake of protein may also
stimulate growth of fat mass, possibly through interplay with
insulin like growth factor-1 as seen in infants [21].
In the present study, the strongest association was found when
matching on BMI and WC, simultaneously. The combination of
these variables captures both total adiposity and body fat
distribution. Body fat distribution is a better indicator of the
adverse state of obesity than adiposity itself, as demonstrated in
relation to mortality in the DCH cohort [22,23]. The possibility
that a beneficial effect of a high protein intake on weight control is
more pronounced among individuals in an adverse state of obesity,
with a combination of higher BMI and WC, needs to be
investigated. Vergnaud et al. [7] found a significant interaction
between BMI (below 25, 25–30 or above 30) and protein intake in
relation to weight change. An association between greater protein
intake and weight gain was seen in all three groups, but the
strongest among individuals with BMI 25–30. However, interac-
tions with other aspects of adiposity and body fat distribution were
not investigated.
The literature on modifying observational data is growing.
Although not related to dietary protein and weight, previous
studies have mimicked a trial in observational data [13,24]. Here
other aspects were important to mimic, e.g. a wash-out period
before initiation of a drug. Several studies have mimicked
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Table 1. Baseline characteristics of the trial, initial cohort data and modified cohort data matched on protein E%, carbohydrate E%,
glycemic index, BMI and WCa.
DiOGenes trial Initial DCH cohort Modified DCH cohort data
N=774 N=57 053b N=2 180
Low proteinc High proteind Low proteine High proteinf
N=196 N=232 N= 784 N= 928
P50 (P5; P95) P50 (P5; P95) P50 (P5; P95) P50 (P5; P95) P50 (P5; P95)
Protein E% 16.7 (12.3; 28.8) 21.4 (14.4; 31.2) 16.7 (12.9; 21.0) 17.1 (12.8; 24.3) 20.4 (15.0; 25.4)
Carbohydrate E% 53.9 (30.6; 68.4) 46.6 (32.2; 58.0) 44.2 (34.0; 55.4) 50.5 (32.5; 61.4) 44.3 (32.8; 54.4)
Fat E% 27.8 (15.6; 43.5) 29.9 (19.8; 47.1) 33.0 (23.7; 40.9) 29.2 (19.9; 39.1) 31.7 (23.6; 40.9)
Alcohol E% 0.0 (0.0; 7.0) 0.0 (0.0; 10.1) 4.2 (0.2; 18.6) 2.1 (0.1; 11.2) 2.7 (0.1; 15.8)
Glycemic index 59.1 (49.6; 67.8) 59.6 (49.5; 69.2) 60.0 (53.6; 66.5) 59.0 (51.2; 66.8) 58.9 (51.1; 67.8)
Energy (MJ) 5.8 (2.8; 10.1) 5.9 (3.5; 10.5) 9.5 (5.9; 14.7) 8.2 (4.9; 13.0) 7.9 (4.9; 12.6)
Weight (kg) 85.0 (67.0; 116.0) 87.4 (65.9; 116.4) 74.5 (54.9; 100.4) 82.0 (65.1; 110.3) 83.5 (65.2; 112.4)
BMI (kg/m2) 30.0 (24.8; 39.4) 29.9 (24.8; 38.9) 25.6 (20.4; 33.4) 28.9 (24.0; 38.3) 29.2 (24.2; 38.1)
WC (cm) 96.4 (80.9; 120.3) 95.8 (80.0; 120.3) 89.0 (69.0; 110.0) 94.0 (79.0; 118.0) 94.0 (78.0; 117.0)
FMI (kg/m2) 11.1 (6.0; 18.2) 10.3 (5.6; 18.7) 7.7 (4.2; 13.9) 10.6 (6.1; 17.6) 10.7 (5.8; 17.8)
Age (years) 41.7 (32.4; 51.6) 42.9 (31.5; 53.1) 56.0 (50.0; 64.0) 54.0 (50.0; 58.0) 53.0 (50.0; 58.0)
Weight change (kg)g 1.4 (26.9; 7.4) 0.7 (211.0; 7.1) 0.0 (21.5; 1.3) 20.1 (21.7; 1.7) 20.1 (22.1; 1.5)
Abbreviations: BMI, body mass index; DCH, Diet Cancer and Health; DiOGenes, Diet Obesity and Genes; E %, percent of energy intake; FMI, fat mass index; P50, median;
P5, 5th percentile; P95, 95th percentile; WC, waist circumference.
aMedian, 5th and 95th percentile of baseline variables and weight change. Information on control groups is not shown. In trial data: high and low protein group is based
on random allocation to intervention diet. In modified cohort data: high and low protein group is based on the randomization status of the matched trial participants.
Mean values across matches of the ten random orders of the trial dataset are shown.
bIndividuals with dietary information N = 56 998; weight N = 57 013; BMI N = 57 009; WC N = 57,000; FMI N = 56 906; age N = 57 053; weight change N = 43 661; glycemic
index only available in the observational DiOGenes study-database N = 22 835.
cIndividuals with information on fat mass (kg), FMI and body fat % N = 169; weight change N = 147.
dIndividuals with information on fat mass (kg), FMI and body fat % N = 192; weight change N = 189.
eIndividuals with information on fat mass, FMI and body fat % N = 782.
fIndividuals with information on fat mass, FMI and body fat % N = 925.
gIn trial data: change in weight during weight loss maintenance phase (mean 6 months). In observational data: average annual change in weight from baseline to
follow-up (mean 5.3 years).
doi:10.1371/journal.pone.0101134.t001
Table 2. Annual weight change effect when comparing cohort individuals matching trial participants randomized to either high or
low protein intakea.
Matching variables Adjusted similar to trial
b Fully adjustedc
b (range) p-valued (range) b (range) p-valued (range)
Diet 0.011 (20.012; 0.034) 0.807 (0.422; 0.999) 20.004 (20.027; 0.020) 0.934 (0.543; 0.955)
Diet and BMI 20.074 (20.138; 20.031) 0.155 (0.008; 0.557) 20.090 (20.152; 20.049) 0.083 (0.003; 0.350)
Diet and WC 20.063 (20.103; 20.006) 0.208 (0.042; 0.903) 20.090 (20.131; 20.032) 0.076 (0.010; 0.530)
Diet and FMI 20.074 (20.125; 20.030) 0.192 (0.027; 0.594) 20.079 (20.132; 20.040) 0.166 (0.021; 0.482)
Diet, BMI and WC 20.118 (20.154; 20.051) 0.025 (0.004; 0.331) 20.142 (20.180; 20.078) 0.008 (,0.001; 0.142)
Abbreviations: BMI, body mass index; E%, percent of energy intake; FMI, fat mass index; WC, waist circumference.
aFive match-combinations: Diet only (Protein E%, carbohydrate E% and glycemic index), diet in combination with BMI, WC or FMI, or diet, BMI and WC. Multiple linear
regression analysis was used. Exposure was indicator variables (yes/no) of matched randomization groups: high protein, high glycemic index, control. Outcome was
average annual weight change between baseline and follow-up (mean 5.3 years). b= difference in body weight change (kg) between high and low protein group. b and
p-values presented as means and summary statistics, respectively, complemented with corresponding ranges across matches of the ten random orders of the trial
dataset.
bAdjustment for BMI and sex (male/female).
cAdjustment for sex (male/female without hormone use/female with hormone use), baseline BMI, age, physical activity (4 groups: inactive, moderately inactive,
moderately active, active), education (4 groups: primary school, technical/professional school, secondary school, university degree) and intake of fibers (g/day) and
alcohol (E%).
dSummary p-values, derived from the means of the b-estimates and of the corresponding standard errors, respectively, over the ten individual matches.
doi:10.1371/journal.pone.0101134.t002
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hypothetical interventions [25–32]. In relation to nutritional
research Lajous et al. [32] investigated the association between
change in fish intake and subsequent long-term risk of coronary
heart disease by mimicking a hypothetical intervention of fish
intake.
The method applied in the present study has the presumed
advantage of mimicking the variation in exposure level followed by
the intention-to-treat type of analysis of the trial. Further, it was
possible to analyze the selected cohort participants according to
the randomly assigned exposure of the trial participant. Otherwise,
it may be problematic to compare results from an ‘‘as-treated’’
analysis in observational data with an intention-to-treat analysis in
trial data. The intention-to-treat analysis does not necessarily
reflect the actual exposure [33]. As seen in Figure 3 and Table 1,
great variation of protein intake existed within the high and low
protein groups of the trial. This shows that the trial did not achieve
a clear distinction of exposure level in accordance with the
randomization status. When matching participants from an
observational cohort study with trial participants, as done in the
present study, it was possible to select a subgroup similar to the
trial participants including the variation in exposure level.
Matching was based on the Euclidean distance metric, but other
methods could also have been used. For example the Mahalanobis
distance [17,18,34] or on related extensions by propensity-like
scores [35]. Future studies may explore such methods. Matching
can be performed both with and, as done here, without
replacement. An advantage of matching with replacement is that
the match will not depend on initial sorting order of trial
participants and that the distances will be globally minimized
(given the used distance metric). However, some individuals,
showing extreme values, may potentially end up with an unduly
large influence on the results as a consequence of being selected
multiple times.
From inspection of scree plots, four iterations were chosen,
which may be considered as arbitrary, but it is unlikely that
notable differences in results would be obtained by choosing, for
instance, three or five iterations.
Several aspects of the trial participants could not be mimicked
in the observational data. Despite 773 trial participants being
randomized to the intervention, only 555 had information on
dietary intake and, of these, 460 had information about FMI.
However, the re-analysis of trial participants with data on diet and
weight change between randomization and post-intervention
(N = 441) showed results similar to the analyses of the initial trial.
Inadequate matching on some variables was also a problem; the
highest values of protein intake among trial participants could not
get a good match in the observational data. This is probably
because the highest intake in the trial generally goes beyond
habitual intake reflected in observational data. However, the re-
analysis of the DiOGenes trial data restricted to participants with
protein intake below 30 E% showed a result essentially similar to
the result of the original DiOGenes trial. Thus, these differences
seemed not to influence the present study.
Various differences were present across the trial and the
observational data, which can potentially be important for the
results. These are discussed in the appendix note in file S1, and
include differences in measurement methods, exposure, follow-up
time as well as the differences between weight change and weight
loss maintenance. However, the hypothesized beneficial effect of a
high-protein diet on weight control may be assumed to be
unaffected by these differences, which is supported by the results of
the present study.
In conclusion, differences between the RCT and observational
data were minimized wherever it seemed possible including
dietary intake, participant characteristics and statistical analysis.
This lead to a modified observational study where a better weight
maintenance was seen in the high protein group than in the low
protein group. The results suggest that participant selection and
analytical strategy may be responsible for the conflicting results
from observational studies and RCTs. Presence of overweight or
obesity, and especially abdominal obesity, may be important to get
a beneficial effect on weight maintenance of a high intake of
protein. If so, the physiological mechanisms of protein intake in
relation to weight control should be reconsidered. RCTs have
found better weight control with high protein diets among
overweight and obese individuals during 6–12 months, but there
may be no obvious basis for recommending a high protein intake
to normal weight individuals as a tool to better weight control.
However, the present investigation and its contribution should be
seen as explorative.
Supporting Information
File S1 Contains the following supporting information files:
Appendix note: Additional Discussion of differences between the
trial and the cohort study. Table S1: Baseline characteristics of
the modified DCH cohort data when different match-combina-
tions are used. Table S2: Fully adjusted model including
adjustment for total energy intake. Average annual weight change
(kg/year) of cohort individuals matching trial participants
randomized to high protein diet compared to cohort individuals
matching trial participants randomized to low protein diet. Table
S3: Results reported in the initial trial and results of supplemen-
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